Angiotensin II binding to angiotensin I-converting enzyme triggers calcium signaling

Hypertension

Volumn 57, Issue 5, 2011, Pages 965-972

  Guimarães, Paola B ^a   Alvarenga, Érika C ^a   Siqueira, Paula D ^a   Paredes Gamero, Edgar J ^a   Sabatini, Regiane A ^a   Morais, Rafael L T ^a   Reis, Rosana I ^b   Santos, Edson L ^c   Teixeira, Luis G D ^a   Casarini, Dulce E ^a   Martin, Renan P ^a   Shimuta, Suma I ^a   Carmona, Adriana K ^a   Nakaie, Clovis R ^a   Jasiulionis, Miriam G ^a   Ferreira, Alice T ^a   Pesquero, Jorge L ^a   Oliveira, Suzana M ^a   Bader, Michael ^d   Costa Neto, Claudio M ^b   Pesquero, João B ^a   more..

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSIDADE FEDERAL DA GRANDE DOURADOS   (Brazil)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

ACE; angiotensin; angiotensin I converting enzyme; calcium; cells; receptors

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANGIOTENSIN[1-7]; BRADYKININ; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE; INOSITOL 1,4,5 TRISPHOSPHATASE; LISINOPRIL;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CONTROLLED STUDY; ENZYME BINDING; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CALCIUM SIGNALING; CELLS, CULTURED; CHO CELLS; CRICETINAE; CRICETULUS; FLOW CYTOMETRY; LISINOPRIL; MICE; PEPTIDYL-DIPEPTIDASE A; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79955468213     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.167171     Document Type: Article

References (36)

1. Wei L, Alhenc-Gelas F, Corvol P, Clauser E. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J Biol Chem. 1991;266:9002-9008 (Pubitemid 21906610)
2. Woodman ZL, Schwager SL, Redelinghuys P, Chubb AJ, van der Merwe EL, Ehlers MR, Sturrock ED. Homologous substitution of ACE C-domain regions with N-domain sequences: effect on processing, shedding, and catalytic properties. Biol Chem. 2006;387:1043-1051. (Pubitemid 44200498)
3. Zaman MA, Oparil S, Calhoun DA. Drugs targeting the renin-angioten-sin- aldosterone system. Nat Rev Drug Discov. 2002;1:621-636.
4. Kohlstedt K, Brandes RP, Muller-Esterl W, Busse R, Fleming I. Angio-tensin-converting enzyme is involved in outside-in signaling in endothe-lial cells. Circ Res. 2004;94:60-67. (Pubitemid 38064099)
5. Fleming I. Signaling by the angiotensin-converting enzyme. Circ Res. 2006;98:887-896.
6. Correa M, Machado J, Carneiro CR, Pesquero JB, Bader M, Travassos LR, Chammas R, Jasiulionis MG. Transient inflammatory response induced by apoptotic cells is an important mediator of melanoma cell engraftment and growth. Int J Cancer. 2005;114:356-363. (Pubitemid 40279954)
7. Sabatini RA, Bersanetti PA, Farias SL, Juliano L, Juliano MA, Casarini DE, Carmona AK, Paiva AC, Pesquero JB. Determination of angiotensin I-converting enzyme activity in cell culture using fluorescence resonance energy transfer peptides. Anal Biochem. 2007;15:255-262. (Pubitemid 46428210)
8. Carmona AK, Schwager SL, Juliano MP, Juliano L, Sturrock ED. A continous fluorescence resonance energy transfer (FRET) angiotensin I-converting enzyme assay. Nat Protoc 2006;1:1971-1976. (Pubitemid 46773320)
9. DeBlasi A, O'Reilly K, Motulsky HJ. Calculating receptor number from binding experiments using same compound as radioligand and com-petitor. Trends Pharmacol Sci. 1989;10:227-229. (Pubitemid 19146394)
10. Setterfield K, Williams AJ, Donald J, Thorburn DR, Kirby DM, Trounce I, Christodoulou J. Flow cytometry in the study of mitochondrial respi-ratory chain disorders. Mitochondrion. 2002;1:437-1445.
11. Santos EL, Souza KP, Sabatini RA, Martin RP, Fernandes L, Nardi DT, Malavolta L, Shimuta SI, Nakaie CR, Pesquero JB. Functional assessment of angiotensin II and bradykinin analogues containing the paramagnetic amino acid TOAC Int Immunopharmacol. 2008;2: 293-299.
12. Giles ME, Fernley RT, Nakamura Y, Moeller I, Aldred GP, Ferraro T, Penschow JD, McKinley MJ, Oldfield BJ. Characterization of a specific antibody to the rat angiotensin II AT1 receptor. J Histochem Cytochem. 1999;47:507-516.
13. Paiva TB, Paiva AC Some pharmacological actions of synthetic ana-logues of angiotensinamide. Br J Pharmacol Chemother. 1960;15: 557-560.
14. Nakaie CR, Silva EG, Cilli EM, Marchetto R, Schreier S, Paiva TB, Paiva AC Synthesis and pharmacological properties of TOAC-labeled angio-tensin and bradykinin analogs. Peptides. 2002;1:65-70. (Pubitemid 34113764)
15. Kondoh G, Tojo H, Nakatani Y, Komazawa N, Murata C, Yamagata K, Maeda Y, Kinoshita T, Okabe M, Taguchi R, Takeda J. Angiotensin-converting enzyme is a GPI-anchored protein releasing factor crucial for fertilization. Nat Med. 2005;11:160-166. (Pubitemid 40321351)
16. Kohlstedt K, Busse R, Fleming I. Signaling via the angiotensin-converting enzyme enhances the expression of cyclooxygenase-2 in en-dothelial cells. Hypertension. 2004;45:126-132.
17. Kohlstedt K, Kellner R, Busse R, Fleming I. Signaling via the angioten-sin-converting enzyme results in the phosphorylation of the nonmuscle myosin heavy chain IIA. Mol Pharmacol. 2006;69:19-26. (Pubitemid 43048889)
18. Sun X, Rentzsch B, Gong M, Eichhorst J, Pankow K, Papsdorf G, Maul B, Bader M, Siems WE. Signal transduction in CHO-cells stably trans-fected with domain-selective forms of murine ACE. Biol Chem. 2010; 391:235-244.
19. Minshall RD, Tan F, Nakamura F, Rabito SF, Becker RP, Marcic B, Erdös EG. Potentiation of the actions of bradykinin by angiotensin I-con-verting enzyme inhibitors: the role of expressed human bradykinin B2 receptors and angiotensin-converting enzyme in CHO cells. Circ Res. 1997;81:848-856. (Pubitemid 27467220)
20. Balyasnikova IV, Danilov SM, Muzykantov VR, Fisher AB. Modulation of angiotensin-converting enzyme in cultured human vascular endothelial cells. In Vitro Cell Dev Biol Anim. 1998;34:545-554. (Pubitemid 29071755)
21. Marchetto R, Schreier S, Nakaie CR. A novel spin-labeled amino and derivative for use in peptide synthesis (9-fluorenylmethyloxycarbonyl)2,2,6, 6-tetramethylpiperidine-N-oxyl-4-amino-4-carboxylic acid. J Am Chem Soc 1993;115:11042-11043.
22. Rice GL, Thomas DA, Grant PJ, Turner AJ, Hooper NM. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J. 2004;383: 45-51. (Pubitemid 39389449)
23. Binevski PV, Sizova EA, Pozdnev VF, Kost OA. Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin- converting enzyme. FEBS Lett. 2003;550:84-88. (Pubitemid 37281362)
24. Rousseau A, Michaud A, Chauvet MT, Lenfant M, Corvol P. The hemo-regulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J Biol Chem. 1995;270:3656-3661.
25. Wei L, Clauser E, Alhenc-Gelas F, Corvol P. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J Biol Chem. 1992;267:13398-13405.
26. Cotton J, Hayashi MA, Cuniasse P, Vazeux G, Ianzer D, Camargo AC Dive V. Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides. Biochemistry. 2002;41: 6065-6071. (Pubitemid 34498912)
27. 2+ in the control of gene expression. Nature. 1997;385:260-265. (Pubitemid 27043726)
28. 2+: physiological regulation and role in apoptosis. Mol Cell Biochem. 1994;135:89-98. (Pubitemid 24279111)
29. Stehno-Bittel L, Luckhoff A, Clapham DE. Calcium release from the nucleus by InsP3 receptor channels. Neuron. 1995;14:163-167.
30. 2+ release sites in non-excitable cells. CurrBiol. 2000;10:8-15. (Pubitemid 30057407)
31. Wolf G. Free radical production and angiotensin. Curr Hypertens Rep. 2000;2:167-173.
32. Zhang H, Schmeisser A, Garlichs CD, Plötze K, Damme U, Mügge A, Daniel WG. Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc Res. 1999;44:215-222. (Pubitemid 29431699)
33. Mancini GB, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG, Wargovich TJ, Mudra H, Lüscher TF, Klibaner MI, Haber HE, Uprichard AC, Pepine AJ, Pitt B. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: the TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation. 1996;94:258-265. (Pubitemid 26266107)
34. Schiffrin EL. Vascular changes in hypertension in response to drug treatment: effects of angiotensin receptor blockers. Can J Cardiol. 2002;suppl A:15A-18A.
35. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-153.
36. Wiemer G, Schölkens BA, Becker RH, Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension. 1991;18:558-563.